S

Sipai Health Technology Co, Ltd
HKEX:314

Watchlist Manager
Sipai Health Technology Co, Ltd
HKEX:314
Watchlist
Price: 5.39 HKD -3.75% Market Closed
Market Cap: 4.1B HKD
Have any thoughts about
Sipai Health Technology Co, Ltd?
Write Note

Sipai Health Technology Co, Ltd
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sipai Health Technology Co, Ltd
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
S
Sipai Health Technology Co, Ltd
HKEX:314
Other Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Other Liabilities
ÂĄ25.5m
CAGR 3-Years
-33%
CAGR 5-Years
11%
CAGR 10-Years
N/A
LBX Pharmacy Chain JSC
SSE:603883
Other Liabilities
ÂĄ14.5m
CAGR 3-Years
-22%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Yifeng Pharmacy Chain Co Ltd
SSE:603939
Other Liabilities
ÂĄ53.9m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
Other Liabilities
ÂĄ12.2m
CAGR 3-Years
-9%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Other Liabilities
ÂĄ12.3m
CAGR 3-Years
-10%
CAGR 5-Years
-13%
CAGR 10-Years
15%
No Stocks Found

Sipai Health Technology Co, Ltd
Glance View

Market Cap
4.1B HKD
Industry
Retail

Sipai Health Technology Co., Ltd. operates as a medical technology and health management company. The company is headquartered in Guangzhou, Guangdong and currently employs 3,269 full-time employees. The company went IPO on 2022-12-23. The Company’s businesses include Specialty Pharmacy Business, Physician Research Assistance Business and Health Insurance Services Business. Specialty Pharmacy Business includes the operation of offline specialty pharmacies and distribution of pharmaceutical products to pharmaceutical companies and other distributors. Physician Research Assistance Business mainly provides integrated services for pharmaceutical companies to assist them in producing clinical trial data that meets the relevant regulatory standards for the pharmaceutical companies to advance to the next phase of clinical or solicit approval of a treatment by the applicable regulatory body. Health Insurance Services Business provides insurance brokerage services including distribution of various health and life insurance products on behalf of insurance carriers.

Intrinsic Value
5.2 HKD
Overvaluation 4%
Intrinsic Value
Price
S

See Also

Back to Top